(Eur Arch Otorhinolaryngol[TA])
12,575 results
  • Improving outcomes in the management of acute external laryngotracheal trauma. [Journal Article]
    Eur Arch Otorhinolaryngol. 2026 Oct 31. [Online ahead of print]Mathews SS, Sargunaraj JJE, … Albert RRAEA
  • CONCLUSIONS: Early intervention remains pivotal for successful management of laryngotracheal trauma. This single institutional study, characterized primarily by early definitive management by an experienced team; was able to achieve favourable outcomes even with the use of simple, readily available, inexpensive materials like - absorbable sutures for mucosal and cartilage approximation, and modified endotracheal tube as stents.
  • Serum IL-4, IL-5, IL-13 and sIgE are associated with short-term loss of disease control in allergic rhinitis: a real-world decision-tree model. [Journal Article]
    Eur Arch Otorhinolaryngol. 2026 Oct 31. [Online ahead of print]Wang L, Ruan B, … Yang YEA
  • CONCLUSIONS: Baseline serum IL-4, IL-5, IL-13, sIgE, and eosinophil count were associated with loss of disease control within 6 months in adults with AR receiving routine pharmacotherapy. The decision-tree model provided an interpretable but preliminary representation of biomarker-based risk stratification. Given the retrospective single-center design and lack of external validation, these findings should be regarded as hypothesis-generating. Prospective multicenter studies and independent external validation are required before clinical implementation. This model pertains to routine pharmacotherapy and was not designed to evaluate outcomes after allergen immunotherapy or nasal surgery.
  • Serum Prestin and Ribeye levels in children with congenital profound sensorineural hearing loss. [Journal Article]
    Eur Arch Otorhinolaryngol. 2026 Oct 31. [Online ahead of print]Kalcioglu MT, Celik S, … Mutlu AEA
  • CONCLUSIONS: Children with congenital profound SNHL exhibited higher serum levels of Prestin and Ribeye than normal-hearing controls. While both biomarkers showed potential, their performance may not yet be sufficient to support their use as standalone clinical tests. Further longitudinal studies with age-matched controls and direct biological validation are required to determine whether these circulating proteins could complement existing audiological assessments of congenital hearing loss.
  • Operating-room polidocanol sclerotherapy for HHT-related epistaxis. [Journal Article]
    Eur Arch Otorhinolaryngol. 2026 Oct 31. [Online ahead of print]Martín-Viguer G, Almanzo S, … García-Piñero AEA
  • CONCLUSIONS: Operating room endonasal polidocanol sclerotherapy was associated with clinically meaningful reduction in epistaxis burden, high patient acceptance, and a favourable safety profile. This approach may represent a valuable option for selected patients with recurrent HHT-related epistaxis requiring structured management beyond an office-based setting.